Drug General Information
Drug ID
D0X7HD
Former ID
DNC010280
Drug Name
CP-810123
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530609]
Structure
Download
2D MOL

3D MOL

Formula
C14H18N4O
Canonical SMILES
CC1=NC2=C(C=C1)OC(=N2)N3CCN4CCC3CC4
InChI
1S/C14H18N4O/c1-10-2-3-12-13(15-10)16-14(19-12)18-9-8-17-6-4-11(18)5-7-17/h2-3,11H,4-9H2,1H3
InChIKey
BSNKYWSMUAGMDO-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Neuronal acetylcholine receptor protein, alpha-7 chain Target Info Inhibitor [530609]
5-hydroxytryptamine receptor 3A Target Info Inhibitor [530609]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Cholinergic synapse
Nicotine addiction
Chemical carcinogenesishsa04726:Serotonergic synapse
NetPath Pathway IL2 Signaling Pathway
PANTHER Pathway Alzheimer disease-amyloid secretase pathway
Nicotinic acetylcholine receptor signaling pathwayP04375:5HT3 type receptor mediated signaling pathway
Reactome Highly calcium permeable postsynaptic nicotinic acetylcholine receptorsR-HSA-975298:Ligand-gated ion channel transport
WikiPathways SIDS Susceptibility Pathways
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic CellWP706:SIDS Susceptibility Pathways
Iron uptake and transport
References
Ref 530609J Med Chem. 2010 Feb 11;53(3):1222-37.Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.
Ref 530609J Med Chem. 2010 Feb 11;53(3):1222-37.Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.